news list
latest news

[Free Online Seminar] Key Points and Countermeasures for the Revision of EP 2.6.7
Recommended for the following individuals! ◼ Quality control (QC) personnel for biopharmaceuticals, cell therapy, and gene therapy products ◼ Those responsible for mycoplasma testing in a GMP environ…
31~35 item / All 35 items
-

A new bioreactor system that achieves ultimate performance in the upstream process has arrived.
The evolved version of the single-use bioreactor system "Biostat STR" series, designed for rapid process development and seamless scale-up to commercial production, has arrived. The latest version, "Biostat STR Generation 3," is equipped with a new automation platform "BIOBRAIN" and the analytical tool "BioPAT(R)." This enables exceptional speed, quality, and productivity. The speed, quality, and productivity from process development to upscaling in your pharmaceutical manufacturing scene will dramatically improve. A stable, predictable, and robust process greatly contributes to providing safe and reliable biopharmaceuticals to patients worldwide, further accelerating your manufacturing operations and business. Please take a look at the details of this outstanding product and its stylish design!
-

New product "Microsart ATMP Fungi Detection Kit"
The new Microsart ATMP Fungi Detection Kit has been announced. It detects bacterial and fungal contamination in just 3 hours, compared to the 14 days required by traditional methods. Previously, it only detected Mycoplasma and Bacteria, but with the addition of Fungi, it has become a much more powerful tool. Additionally, a new Sterility Release kit has been introduced, which includes the Bacteria kit, Fungi kit, and DNA extraction kit.
-
Zaltrius Notice Regarding Measures Against the Novel Coronavirus Infection
In response to the spread of the novel coronavirus infection, Sartorius Japan will continuously inform you about the measures we are taking. Information on novel coronavirus measures https://sartorius-if.smktg.jp/public/seminar/view/218
-
Notice of Seminar Cancellation at Regenerative Medicine EXPO and Seminar Follow-up Information
Sartorius Stedim Japan Co., Ltd. has decided to actively withdraw from participation in the "Regenerative Medicine EXPO Osaka" (Intex Osaka) scheduled to be held from February 26, considering the health and safety of participants and stakeholders in light of the ongoing spread of the novel coronavirus infection. Although we will have a booth prepared, we will not be displaying products and will provide unmanned support. As a result, all seminars related to the following products and technologies, which would gather a large number of participants, will be canceled. We sincerely apologize to those who were hoping to attend and ask for your understanding in this matter. Additionally, information and catalogs regarding the seminar-related products and services can be viewed below. If you are interested, please feel free to contact us. ▼ Canceled Seminars February 26 (Wed) 11:00–11:30 Manufacturing and Process Development of Viral Vectors February 28 (Fri) 11:00–11:30 Testing Packages for Cell Therapy and Gene Therapy ■ Contact Information Representative: 03-6478-5201 hp.info@SARTORIUS.com
-

Announcement of Brand Renewal - Simplifying Progress
The Sartorius brand has been providing innovative products and solutions to support scientists and engineers around the world for 150 years. On February 17, 2020, we are pleased to announce that we have renewed our trademark. After a long period of discussion and preparation, our brand identity has been revitalized. In this renewal, we have updated the brand design at both the group and departmental levels, launching a new logo and a simpler brand architecture. Additionally, we would like to draw your attention to the fact that we have updated our new corporate message to "Simplify Progress." As the new message suggests, our products and technologies aim to simplify your operations and contribute to the acceleration of advancements in medicine.